{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:58:51Z","timestamp":1793347131734,"version":"4.5.0"},"reference-count":76,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MH CZ\u2014DRO, Institute of Endocrinology E\u00da","award":["00023761"],"award-info":[{"award-number":["00023761"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) and idiopathic hirsutism (IH) are androgen excess disorders requiring the determination of classic androgen levels for diagnosis. 11-oxygenated androgens have high androgenic potential, yet their clinical value in those disorders is not clear. Additionally, the role of endocrine disruptors (EDs), particularly in IH, remains understudied. We analyzed 25 steroids and 18 EDs in plasma samples from women with IH, PCOS, and controls using LC-MS\/MS. Cytokine levels and metabolic parameters were assessed. Comparisons included non-obese women with PCOS (n = 10), women with IH (n = 12) and controls (n = 20), and non-obese versus obese women with PCOS (n = 9). Higher levels of 11-oxygenated androgens were observed in women with PCOS compared to those with IH, but not controls. Conversely, 11-oxygenated androgen levels were lower in women with IH compared to controls. Cytokine levels did not differ between women with IH and controls. Bisphenol A (BPA) levels were higher in obese women with PCOS compared to non-obese women with PCOS. Bisphenol S occurrence was higher in women with PCOS (90%) compared to controls (65%) and IH (50%). Significant correlations were found between androgens (11-ketotestosterone, androstenedione, testosterone) and insulin and HOMA-IR, as well as between immunomodulatory 7-oxygenated metabolites of DHEA and nine interleukins. Our data confirms that PCOS is a multiendocrine gland disorder. Higher BPA levels in obese women might exacerbate metabolic abnormalities. IH was not confirmed as an inflammatory state, and no differences in BPA levels suggest BPA does not play a role in IH pathogenesis.<\/jats:p>","DOI":"10.3390\/ijms25179691","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T05:59:08Z","timestamp":1725861548000},"page":"9691","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-7602","authenticated-orcid":false,"given":"Jana","family":"Vitku","sequence":"first","affiliation":[{"name":"Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4065-8619","authenticated-orcid":false,"given":"Anezka","family":"Varausova","sequence":"additional","affiliation":[{"name":"Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1938-6946","authenticated-orcid":false,"given":"Tereza","family":"Skodova","sequence":"additional","affiliation":[{"name":"Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-4598","authenticated-orcid":false,"given":"Lucie","family":"Kolatorova","sequence":"additional","affiliation":[{"name":"Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michala","family":"Vosatkova","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-0580","authenticated-orcid":false,"given":"Josef","family":"Vcelak","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Vrbikova","sequence":"additional","affiliation":[{"name":"Department of Clinical Endocrinology, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0417-9867","authenticated-orcid":false,"given":"Marketa","family":"Simkova","sequence":"additional","affiliation":[{"name":"Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-1447","authenticated-orcid":false,"given":"Michaela","family":"Svojtkova","sequence":"additional","affiliation":[{"name":"Department of Steroids and Proteofactors, Institute of Endocrinology, Narodni 8, 116 94 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.beem.2006.02.004","article-title":"Diagnosis of hyperandrogenism: Clinical criteria","volume":"20","author":"Yildiz","year":"2006","journal-title":"Best Pr. Res. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1210\/clinem\/dgac652","article-title":"Screening for Adverse Metabolic Consequences in Women with Idiopathic Hirsutism\u2014Is it Relevant?","volume":"108","author":"Dimakopoulou","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: Experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2013.07.006","article-title":"11\u03b2-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: A putative role in castration resistant prostate cancer?","volume":"377","author":"Storbeck","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome","volume":"102","author":"Kempegowda","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr. J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E.M., Shawki, H.E.-D., and Amer, S. (2021). The Role of Chronic Inflammation in Polycystic Ovarian Syndrome\u2014A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052734"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbi.2007.07.003","article-title":"Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome","volume":"22","author":"Benson","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A.M., Smolarczyk, R., and Meczekalski, B. (2021). Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073789"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2302402","DOI":"10.1080\/09513590.2024.2302402","article-title":"Correlation between chronic low-grade inflammation and glucose and lipid metabolism indicators in polycystic ovary syndrome","volume":"40","author":"Zhou","year":"2024","journal-title":"Gynecol. Endocrinol."},{"key":"ref_12","first-page":"S279","article-title":"Endocrine Disruptors, Obesity, and Cytokines\u2014How Relevant Are They to PCOS?","volume":"69","year":"2020","journal-title":"Physiol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis","volume":"95","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/01443615.2011.553693","article-title":"Polycystic ovary syndrome and the peripheral blood white cell count","volume":"31","author":"Herlihy","year":"2011","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0304-4165(99)00124-5","article-title":"The 7\u03b1-hydroxysteroids produced in human tonsils enhance the immune response to tetanus toxoid and Bordetella pertussis antigens","volume":"1472","author":"Lafaye","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_17","first-page":"238","article-title":"Dexamethasone-induced apoptosis of mouse thymocytes: Prevention by native 7\u03b1-hydroxysteroids. Immunol","volume":"78","author":"Chmielewski","year":"2000","journal-title":"Cell Biol."},{"key":"ref_18","first-page":"S285","article-title":"The Origin of 7\u03b1-Hydroxy-Dehydroepiandrosterone and Its Physiological Role: A History of Discoveries","volume":"66","year":"2017","journal-title":"Physiol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2006.03.001","article-title":"The native anti-glucocorticoid paradigm","volume":"100","author":"Muller","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.steroids.2003.12.006","article-title":"Antioxidant effects of dehydroepiandrosterone and 7\u03b1-hydroxy-dehydroepiandrosterone in the rat colon, intestine and liver","volume":"69","author":"Pelissier","year":"2004","journal-title":"Steroids"},{"key":"ref_21","first-page":"347","article-title":"Idiopathic Hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1111\/jocd.15070","article-title":"Insulin resistance and idiopathic hirsutism: A systematic review, meta-analysis, and meta-regression","volume":"21","author":"Amiri","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/clinem\/dgac538","article-title":"Idiopathic Hirsutism and Metabolic Status: A Population-based Prospective Cohort Study","volume":"108","author":"Mahmoudieh","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2047","DOI":"10.1210\/clinem\/dgab920","article-title":"Clinical Value of Serum Levels of 11-Oxygenated Metabolites of Testosterone in Women with Polycystic Ovary Syndrome","volume":"107","author":"Tosi","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"bvac037","DOI":"10.1210\/jendso\/bvac037","article-title":"11-Oxyandrogens in Adolescents with Polycystic Ovary Syndrome","volume":"6","author":"Taylor","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1210\/clinem\/dgaa063","article-title":"Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations","volume":"105","author":"Skiba","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement","volume":"30","author":"Bourguignon","year":"2009","journal-title":"Endocr. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mce.2006.04.033","article-title":"Endocrine disruptors and reproductive health: The case of bisphenol-A. Mol","volume":"254\u2013255","author":"Maffini","year":"2006","journal-title":"Cell. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.fertnstert.2010.09.026","article-title":"Urine bisphenol-A (BPA) level in relation to semen quality","volume":"95","author":"Li","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1289\/ehp.6601","article-title":"Neurodevelopment and endocrine disruption","volume":"112","author":"Colborn","year":"2004","journal-title":"Environ. Heal. Perspect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod. Toxicol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Corti, M., Lorenzetti, S., Ubaldi, A., Zilli, R., and Marcoccia, D. (2022). Endocrine Disruptors and Prostate Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031216"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-019-09521-z","article-title":"Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention","volume":"21","author":"Yilmaz","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Dalamaga, M., Kounatidis, D., Tsilingiris, D., Vallianou, N.G., Karampela, I., Psallida, S., and Papavassiliou, A.G. (2024). The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010675"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1210\/jc.2010-1658","article-title":"Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS","volume":"96","author":"Kandaraki","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/hmbci-2020-0032","article-title":"Urinary bisphenol A in women with polycystic ovary syndrome\u2014A possible suppressive effect on steroidogenesis?","volume":"42","year":"2021","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1507\/endocrj.51.165","article-title":"Positive Relationship between Androgen and the Endocrine Disruptor, Bisphenol A, in Normal Women and Women with Ovarian Dysfunction","volume":"51","author":"Takeuchi","year":"2004","journal-title":"Endocr. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ijgo.15349","article-title":"Bisphenol A and polycystic ovary syndrome in human: A systematic review","volume":"166","author":"Urbanetz","year":"2024","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"115962","DOI":"10.1016\/j.envpol.2020.115962","article-title":"Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome\u2014Is there an association?","volume":"272","author":"Jurewicz","year":"2021","journal-title":"Environ. Pollut."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"117440","DOI":"10.1016\/j.cca.2023.117440","article-title":"Association of classic and 11-oxygenated androgens with polycystic ovaries and menstrual cycle prolongation in infertile women with PCOS","volume":"547","author":"Ma","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/GME.0000000000001116","article-title":"Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis","volume":"25","author":"Moslehi","year":"2018","journal-title":"Menopause"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1210\/clinem\/dgaa436","article-title":"Increased Body Mass Index Is Associated with a Nondilutional Reduction in Antim\u00fcllerian Hormone","volume":"105","author":"Jaswa","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","first-page":"4589","article-title":"11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex Differences in 11-Oxygenated Androgen Patterns Across Adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ejendo\/lvac017","article-title":"Classic and 11-oxygenated androgens in serum and saliva across adulthood: A cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation","volume":"188","author":"Schiffer","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1093\/ejendo\/lvad047","article-title":"The clinical and biochemical significance of 11-oxygenated androgens in human health and disease","volume":"188","author":"Storbeck","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2143\/ACB.3267","article-title":"Update on idiopathic hirsutism: Diagnosis and treatment","volume":"68","author":"Erem","year":"2013","journal-title":"Acta Clin. Belg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-94-024-0921-5_2","article-title":"The Interleukin-1 Family","volume":"941","author":"Yazdi","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1677\/JOE-07-0638","article-title":"Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells","volume":"197","author":"Elsner","year":"2008","journal-title":"J. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100687","DOI":"10.1016\/j.bbih.2023.100687","article-title":"Putative role of immune reactions in the mechanism of tardive dyskinesia","volume":"33","author":"Loonen","year":"2023","journal-title":"Brain Behav. Immun. Heal."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and anti-gen-specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/prd.12083","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation","volume":"69","author":"Zenobia","year":"2015","journal-title":"Periodontology 2000"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bhavsar, I., Miller, C.S., and Al-Sabbagh, M. (2015). Macrophage Inflammatory Protein-1 Alpha (MIP-1 alpha)\/CCL3: As a Biomarker. General Methods in Biomarker Research and Their Applications, Springer.","DOI":"10.1007\/978-94-007-7696-8_27"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.4049\/jimmunol.150.11.4996","article-title":"Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines","volume":"150","author":"Widmer","year":"1993","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Luotola, K. (2022). IL-1 Receptor Antagonist (IL-1Ra) Levels and Management of Metabolic Disorders. Nutrients, 14.","DOI":"10.3390\/nu14163422"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0091-6749(98)70080-6","article-title":"The role of IL-13 and its receptor in allergy and inflammatory responses","volume":"102","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Taneja, V. (2018). Sex Hormones Determine Immune Response. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01931"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Stelzer, I.A., and Arck, P.C. (2016). Immunity and the Endocrine System. Encyclopedia of Immunobiology, Academic Press. Volume 5: Physiology and Immune System Dysfunction.","DOI":"10.1016\/B978-0-12-374279-7.19001-0"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mihaylova, Z., Tsikandelova, R., Sanimirov, P., Gateva, N., Mitev, V., and Ishkitiev, N. (2018). Role of PDGF-BB in proliferation, differentiation and maintaining stem cell properties of PDL cells in vitro. Arch. Oral. Biol., 85.","DOI":"10.1016\/j.archoralbio.2017.09.019"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.21037\/apm-21-1003","article-title":"The expression of platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor-II in patients with polycystic ovary syndrome and its correlation with pregnancy outcomes","volume":"10","author":"Gao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100310","DOI":"10.1016\/j.clinsp.2023.100310","article-title":"Does bisphenol A (BPA) participates in the pathogenesis of Polycystic Ovary Syndrome (PCOS)?","volume":"78","author":"Urbanetz","year":"2023","journal-title":"Clinics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11154-016-9326-7","article-title":"Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)","volume":"16","author":"Palioura","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ijo.2012.173","article-title":"The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11\u03b2-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children","volume":"37","author":"Wang","year":"2013","journal-title":"Int. J. Obes."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1038\/nutd.2013.43","article-title":"Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist","volume":"4","author":"Boucher","year":"2014","journal-title":"Nutr. Diabetes"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"137463","DOI":"10.1016\/j.chemosphere.2022.137463","article-title":"Exposure to bisphenol A and its analogs and polycystic ovarian syndrome in women of childbearing age: A multicenter case-control study","volume":"313","author":"Zhan","year":"2023","journal-title":"Chemosphere"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.toxrep.2017.10.006","article-title":"Bisphenol S impairs blood functions and induces cardiovascular risks in rats","volume":"4","author":"Pal","year":"2017","journal-title":"Toxicol. Rep."},{"key":"ref_68","first-page":"123294","article-title":"An LC-MS\/MS method for the simultaneous quantification of 32 steroids in human plasma","volume":"1201\u20131202","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"115083","DOI":"10.1016\/j.ecoenv.2023.115083","article-title":"Derivatized versus non-derivatized LC-MS\/MS techniques for the analysis of estrogens and estrogen-like endocrine disruptors in human plasma","volume":"260","author":"Vitku","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S411","DOI":"10.33549\/physiolres.935246","article-title":"Endocrine Disruptors and Estrogens in Human Prostatic Tissue","volume":"72","author":"Vitku","year":"2023","journal-title":"Physiol. Res."},{"key":"ref_71","first-page":"S379","article-title":"Androgens in women\u2014Critical evaluation of the methods for their determination in diagnostics of endocrine disorders","volume":"67","year":"2018","journal-title":"Physiol. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.talanta.2017.05.070","article-title":"Determination of selected bisphenols, parabens and estrogens in human plasma using LC-MS\/MS","volume":"174","author":"Sosvorova","year":"2017","journal-title":"Talanta"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.talanta.2015.03.013","article-title":"Development and validation of LC\u2013MS\/MS method for quantification of bisphenol A and estrogens in human plasma and seminal fluid","volume":"140","author":"Vitku","year":"2015","journal-title":"Talanta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.33549\/physiolres.934124","article-title":"A method for determination of one hundred endogenous steroids in human serum by gas chromatography-tandem mass spectrometry","volume":"68","author":"Hill","year":"2019","journal-title":"Physiol. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","article-title":"Estimation of Average Concentration in the Presence of Nondetectable Values","volume":"5","author":"Hornung","year":"1990","journal-title":"Appl. Occup. Environ. Hyg."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/17\/9691\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:50:10Z","timestamp":1760111410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/17\/9691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":76,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms25179691"],"URL":"https:\/\/doi.org\/10.3390\/ijms25179691","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]}}}